Welcome to ProAxsis

ProAxsis is developing a range of products for the capture, detection and measurement of active protease biomarkers of disease.

Our rapid and easy-to-use tests incorporate patented ProteaseTags®; smart molecules which trap an active protease within a complex biological sample and enable a visual readout of its presence. A number of active protease species have been extensively validated as biomarkers of disease activity in areas such as cancer and infection, in addition to respiratory diseases such as cystic fibrosis and COPD. 

 

 

NEATstik-LFD ELISAkit

CLINICAL RESEARCH SERVICES
ACTIVITY PROFILING
TARGET VALIDATION
CLINICAL TRIAL SUPPORT 

CLINICAL/POINT OF CARE TESTS
ProteaseTags®
CROSS PLATFORM TECHNOLOGY

ProteaseTag® Immunoassays
KIT SALES
SERVICE PROVISION
DRUG DISCOVERY

SMART MOLECULE DESIGN
ProteaseTags® LIBRARY
INHIBITOR/KINETIC ANALYSIS
CUSTOM DESIGN & SYNTHESIS

News

ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016
ProAxsis (www.proaxsis.com) was delighted to observe that measuring active neutrophil elastase (NE) by ...
ProAxsis to present at 2016 North American Cystic Fibrosis Conference
   ProAxsis will this week be presenting new data on its ProteaseTag® technology, at the North Americ...
ProAxsis receives Royal visit
ProAxsis were this week delighted to host His Royal Highness, the Duke of York, at their new laborat...
ProAxsis gains CE Mark for Active Neutrophil Elastase Immunoassay
ProAxsis Limited (www.proaxsis.com) is pleased to announce that it has successfully registered a CE Mar...
Proaxsis